Subject: To understand the treatment preference in the management of platinum sensitive relapsed ovarian cancer
As per Globocan data, incidences of ovarian cancer are 48,014 in India. Among them 22,687 patients are suffering from platinum sensitive relapsed ovarian cancer.
Currently for the management of platinum sensitive relapsed ovarian cancer (PSROC), there 3 different treatment regimen options are being used. As there are multiple treatment choices available for the management of PSROC, thorough understanding of doctor’s choices in partially and completely platinum sensitive patients depending on varying platinum free intervals is crucial.
We invite you to participate in this survey and share relevant information about the management of platinum sensitive relapsed ovarian cancer in real world practice in India.
We trust you and we are partners in promoting safe effective medical therapy. In that spirit we hope you will consent to participate in this study. If you do, please sign and return the enclosed reply along with your visiting card for accuracy of records.
|
}}){kind=logo}
}})